Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | AZN | AMGN | GILD | BMY |
| Company | Abcellera Biologics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.36 | 198.71 | 340.99 | 139.00 | 59.12 |
| High | 3.38 | 201.80 | 341.87 | 139.39 | 59.23 |
| Low | 3.22 | 196.95 | 335.06 | 137.15 | 57.66 |
| Latest | 3.28 | 200.96 | 339.14 | 138.23 | 57.76 |
| Change | -0.11 | -1.87 | -3.43 | -1.90 | -1.57 |
| % Change | -3.24% | -0.92% | -1.00% | -1.36% | -2.65% |
| Volume | 3,037,474 | 1,969,136 | 1,758,392 | 2,593,877 | 4,531,147 |
| 20-Day Average Volume | 2,446,568 | 1,838,469 | 2,601,768 | 5,957,695 | 13,253,389 |
| Previous Close | 3.39 | 202.83 | 342.57 | 140.13 | 59.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.45 | 192.15 | 355.09 | 140.66 | 59.14 |
| 20-Day Raw Stochastic | 17.78% | 83.56% | 8.78% | 29.89% | 25.19% |
| 20-Day Relative Strength | 45.13 | 57.24 | 38.74 | 46.16 | 46.37 |
| Weighted Alpha | +9.73 | +50.01 | +17.85 | +32.55 | +19.61 |
| Today's Opinion | 88% Sell | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 88% Sell | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 80% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.61% since 03/30/26 | +3.71% since 03/30/26 | -2.72% since 03/30/26 | +1.60% since 03/30/26 | -3.06% since 03/30/26 |
| Low | 3.22 on 04/07/26 | 193.55 on 03/31/26 | 335.59 on 04/07/26 | 137.17 on 04/07/26 | 57.89 on 04/07/26 |
| High | 3.67 on 04/01/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -4.35% since 03/06/26 | +3.53% since 03/06/26 | -8.13% since 03/06/26 | -3.76% since 03/06/26 | -3.96% since 03/06/26 |
| Low | 3.22 on 04/07/26 | 182.39 on 03/24/26 | 335.59 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 3.67 on 04/01/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -20.10% since 01/07/26 | +5.65% since 01/07/26 | -0.63% since 01/07/26 | +11.40% since 01/07/26 | +2.09% since 01/07/26 |
| Low | 2.74 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 4.85 on 01/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -42.81% since 10/07/25 | +17.08% since 10/07/25 | +14.87% since 10/07/25 | +18.62% since 10/07/25 | +29.66% since 10/07/25 |
| Low | 2.74 on 02/05/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 6.51 on 10/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,027,712 | 314,570,656 | 184,668,512 | 173,932,464 | 121,136,144 |
| Shares Outstanding, K | 303,160 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 75,130,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -146,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 44,850,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -8,950,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.85 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 02/24/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/11/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.22 | 15.92 | 17.14 | 9.69 |